NCT06545292View on ClinicalTrials.gov

Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients

NANot yet recruitingINTERVENTIONAL

Enrollment

360

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

July 1, 2027

Conditions

Drug Monitoring

Interventions

DIAGNOSTIC_TEST

Therapeutic drug monitoring with a dried blood spot and microatainer.

Patients who use an oral oncolytic will be asked to provide twelve microsamples obtained by finger prick (eight dried blood spots (DBS) and four wet blood samples in microtainer EDTA) and four paired whole blood (WB) samples obtained by venapuncture.

All Listed Sponsors

lead

Leiden University Medical Center

OTHER

NCT06545292 - Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients | Biotech Hunter | Biotech Hunter